A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Autor: Khalaf, Daniel Joseph1 daniel.khalaf@bccancer.bc.ca, Avilés, Claudia M.1, Azad, Arun A.2, Sunderland, Katherine1, Todenhöfer, Tilman3, Eigl, Berhard J.1, Finch, Daygen4, Le, Lyly5, Atwell, Andrew6, Keith, Bruce7, Kollmannsberger, Christian1, Chi, Kim. N.1,3
Zdroj: Canadian Urological Association Journal. Feb2018, Vol. 12 Issue 2, pE47-E52. 6p.
Databáze: Academic Search Ultimate